Description
Renapine XR 50 mg is an extended-release formulation of Quetiapine Fumarate, manufactured by Renata Limited. It is primarily used in the treatment of schizophrenia, bipolar disorder (including manic and depressive episodes), and as an adjunct in major depressive disorder. The extended-release formulation allows for once-daily dosing, which can improve patient adherence to the treatment regimen. Renapine XR 50 mg is typically taken orally, with or without food, and should be swallowed whole without crushing or chewing.
.webp)
.webp)
.webp)
.jpg)
 50500 mg.jpeg)
.webp)
.webp)
.webp)
.webp)
.jpeg)
.webp)
.webp)
.jpg)
Change Language